BCAL Diagnostics Limited (ASX:BDX)

BCAL Diagnostics Statistics

Total Valuation

ASX:BDX has a market cap or net worth of AUD 42.33 million. The enterprise value is 40.18 million.

Market Cap	42.33M
Enterprise Value	40.18M

Important Dates

The last earnings date was Friday, August 29, 2025.

Earnings Date	Aug 29, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:BDX has 368.07 million shares outstanding. The number of shares has increased by 46.04% in one year.

Current Share Class	368.07M
Shares Outstanding	368.07M
Shares Change (YoY)	+46.04%
Shares Change (QoQ)	-3.99%
Owned by Insiders (%)	29.26%
Owned by Institutions (%)	6.36%
Float	177.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.97
PB Ratio	6.80
P/TBV Ratio	6.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.55
EV / Sales	15.16
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.80

Financial Position

The company has a current ratio of 2.32, with a Debt / Equity ratio of 0.38.

Current Ratio	2.32
Quick Ratio	2.29
Debt / Equity	0.38
Debt / EBITDA	n/a
Debt / FCF	-0.34
Interest Coverage	-76.48

Financial Efficiency

Return on equity (ROE) is -97.79% and return on invested capital (ROIC) is -47.01%.

Return on Equity (ROE)	-97.79%
Return on Assets (ROA)	-39.67%
Return on Invested Capital (ROIC)	-47.01%
Return on Capital Employed (ROCE)	-103.48%
Weighted Average Cost of Capital (WACC)	7.88%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.24
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.52% in the last 52 weeks. The beta is 0.71, so ASX:BDX's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	+9.52%
50-Day Moving Average	0.11
200-Day Moving Average	0.08
Relative Strength Index (RSI)	49.10
Average Volume (20 Days)	511,757

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:BDX had revenue of AUD 2.65 million and -7.24 million in losses. Loss per share was -0.02.

Revenue	2.65M
Gross Profit	2.65M
Operating Income	-7.04M
Pretax Income	-7.24M
Net Income	-7.24M
EBITDA	-6.31M
EBIT	-7.04M
Loss Per Share	-0.02

Balance Sheet

The company has 4.52 million in cash and 2.38 million in debt, with a net cash position of 2.14 million or 0.01 per share.

Cash & Cash Equivalents	4.52M
Total Debt	2.38M
Net Cash	2.14M
Net Cash Per Share	0.01
Equity (Book Value)	6.22M
Book Value Per Share	0.02
Working Capital	4.09M

Cash Flow

In the last 12 months, operating cash flow was -6.14 million and capital expenditures -787,675, giving a free cash flow of -6.92 million.

Operating Cash Flow	-6.14M
Capital Expenditures	-787,675
Free Cash Flow	-6.92M
FCF Per Share	-0.02

Margins

Gross margin is 100.00%, with operating and profit margins of -265.55% and -273.21%.

Gross Margin	100.00%
Operating Margin	-265.55%
Pretax Margin	-273.21%
Profit Margin	-273.21%
EBITDA Margin	-238.01%
EBIT Margin	-265.55%
FCF Margin	n/a

Dividends & Yields

ASX:BDX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-46.04%
Shareholder Yield	-46.04%
Earnings Yield	-17.11%
FCF Yield	-16.36%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:BDX has an Altman Z-Score of 0.56 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.56
Piotroski F-Score	2